Job Description

At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.

Job Description

• Inform the future disease strategy for new compounds, primarily on the hematology and cell therapy side of the business, and support oncology, cardiovascular, immunology and fibrosis as guided by the manager by ensuring optimal clinical development strategies are being assessed and define a set of mitigation activities and evidence generation plan to address key market access and pricing challenges pre-identified
• Build and establish internal relationships and enhance interactions with stakeholders in both field based functional market roles as well as senior worldwide management. We are looking for an exceptional candidate who is inclusive, focused, ambitious, decisive and motivated by high goals
• Monitor the evolving external environment and synthesize input to inform Market Access strategies to ensure that VAP/HEOR considerations are included in protocol design (e.g., relevant endpoints, comparator, dosing, study population, subpopulation of interest) as well as the development of mitigation activities in collaboration with the cross-functional team (WW Pricing, WW HEOR, WW Medical & Local Markets)
• Influence across the enterprise, creating effective and sustainable relationships within the matrix and positively inform strategic development and commercialization decisions and determine a set of criteria to selected early assets
• Contribute to shape an efficient process in collaboration with the Early Assets Commercialization teams to timely inform the overall asset strategy across the portfolio and throughout the drug’s life cycle with the focus on GT2/3 through G4 by leveraging Early Access Review Checklists (EAR) and similar frameworks to provide input to the regulatory & pricing department
• Lead activities to support Early Assets and Business Development requests from matrix partners and collaborate with the Market Access Strategy Leads prior to GT5
• Co-create the framework in collaboration with the Commercial and Clinical team that will assess attractiveness of Business Development requests and optimize registrational trial designs
• The position is cross-functional in nature and is part of a highly matrixed organization and the Director will partner with cross-functional VAP/HEOR teams as well as with extended teams (Commercial, Medical, Biomarker, Regulatory, Clinical, Advocacy, Policy, Business Insights & Analytics WW leads) as well as the relevant individual market stakeholders across the world to optimally position BMS products for success in an increasingly challenging and evolving WW access landscape
• Build and establish Access Biomarker strategies and inform tactical execution within the matrix teams
• Collaborate with WW Value & Segmentation Marketing and WW “in region” Market Access to prepare for the operational execution of the WW Market Access strategy: training of key markets and early launch markets through VAP meeting & Local interactions, support for the initiation of the Early Access Strategy and Evidence Generation Plan
• Ensure that all recommended Market Access activities comply with regulatory agencies, public policies/guidelines, and with corporate/legal policies and procedures and if required, lead a team of people

Requirements:

• Minimum of 10 years’ Market Access experience with an exceptional track record in Market Access, Pricing or HEOR in WW and/or local markets
• Strong understanding of the current and emerging global Market Access environment in our therapeutic areas of interest with experience in taking multiple products to market and developing HTA strategies
• Highly specialized technical expert, highly specialized Market Access, Pricing and Reimbursement expertise, knowledge of rapidly emerging HTA systems and data requirements
• Comprehensive knowledge of the drug development & commercialization process, HTA assessment methodologies, global reimbursement environment, and regulatory requirements an in-depth understanding of payers and their perspective in the key WW markets
• Solid scientific background, preferably within hematology and/or oncology, enabling the assessment of trial design impact on payer strategies and the ability to challenge clinical development or medical affairs or other relevant stakeholders with the ability to identify relevant clinical endpoints and plan for outcomes research in the early phases of clinical trial development
• Ability to identify key product advantages in the context of market requirements and provides key ideas for developing individual value stories around BMS products
• Excellent strategic thinking and written/oral communication skills
• Demonstrated ability to formulate future Market Access strategy scenarios and lead cross-functional teams, with or without formal authority, to act on these scenarios
• Proven ability to translate scientific/clinical value into economic value
• Demonstration of all BMS Core Behaviors
• Undergraduate degree required, MBA and/or post graduate degree preferred

Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. 

Physical presence at the BMS worksite or physical presence in the field is an essential job function of this role which the Company deems critical to collaboration, innovation, productivity, employee well-being and engagement, and enhances the Company culture.

To protect the safety of our workforce, customers, patients and communities, the policy of the Company requires all employees and workers in the U.S. and Puerto Rico to be fully vaccinated against COVID-19, unless they have received an exception based on an approved request for a medical or religious reasonable accommodation.  Therefore, all BMS applicants seeking a role located in the U.S. and Puerto Rico must confirm that they have already received or are willing to receive the full COVID-19 vaccination by their start date as a qualification of the role and condition of employment.  This requirement is subject to state and local law restrictions and may not be applicable to employees working in certain jurisdictions such as Montana. This requirement is also subject to discussions with collective bargaining representatives in the U.S.

Our company is committed to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an approval of accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application or if you are applying to a role based in the U.S. or Puerto Rico and you believe that you are unable to receive a COVID-19 vaccine due to a medical condition or sincerely held religious belief, during or any part of the recruitment process, please direct your inquiries to adastaffingsupport@bms.com. Visit careers.bms.com/eeo-accessibility to access our complete Equal Employment Opportunity statement.

Any data processed in connection with role applications will be treated in accordance with applicable data privacy policies and regulations.